|
|
|
Funding Opportunities |
|
Federal Agencies |
|
|
|
National
Institutes of Health |
 |
View |
NIAMS Building Interdisciplinary Research
Team (BIRT) Revision Awards (R01) |
|
|
| |
|
Purpose of this
opportunity is to promote interdisciplinary research, the NIAMS
plans to provide up to 1 year of research revision support (formerly
referred to as “competitive supplements”) to active NIAMS R01s
(parent grants) to establish collaborations among groups of
investigators with expertise in the specific areas listed below. The
interdisciplinary collaboration should be basic and/or translational
research with high innovation and potentially high impact in the
specific NIAMS mission–relevant areas solicited in this FOA. It is
understood that such an application may entail high risk. Teams
developed under this award are expected to make significant advances
beyond the progress expected from the individual researchers alone.
Collaborations between scientific areas listed below are selected to
pilot the NIAMS BIRT awards and specifically solicited in this FOA.
In the following areas: Autoimmunity – Gender and sex factors,
Autoimmunity– Systems biology, Developmental biology – Systems
biology, Regenerative Medicine – Immunology, Soft tissue biology –
Imaging technologies, Tissue engineering –Developmental biology |
|
|
| |
|
|
|
|
| |
|
Letters of Intent
Receipt Date(s): January 19, 2009;
Application Due Date(s): February
19, 2009 |
|
|
| |
|
|
View |
Research on Causal Factors and Interventions
that Promote and Support the Careers of Women in Biomedical and
Behavioral Science and Engineering (R01) |
|
|
| |
|
Purpose of this funding opportunity is to
support research on: 1)causal factors explaining the current
patterns observed in the careers of women in biomedical and
behavioral science and engineering and variation across different
subgroups and 2) the efficacy of programs designed to support the
careers of women in these disciplines. Causal factors include
individual characteristics, family and economic circumstances,
disciplinary culture or practices, and features of the broader
social and cultural context. Research on variation among
underrepresented minority women and socioeconomically disadvantaged
women is encouraged. |
|
|
| |
|
|
|
|
| |
|
Letter of Intent Receipt Date(s): September 21,
2008; Application
Submission/Receipt Date(s):
October 22, 2008 |
|
|
| |
|
|
View |
Outstanding New Environmental Scientist Award (ONES) (R01) |
|
|
| |
|
Outstanding
New Environmental Scientist Award is intended to identify
outstanding scientists who are in the early, formative stages of
their careers and who intend to make a long term career commitment
to research in the mission areas of the NIEHS and assist them in
launching an innovative research program focusing on problems of
environmental exposures and human biology, human pathophysiology and
human disease. |
|
|
| |
|
|
|
|
| |
|
Letters of Intent
Receipt Date(s): October 1, 2008.
Application Due Date(s): October
31, 2008 |
|
|
| |
|
|
View |
IDeA Networks of Biomedical Research
Excellence (INBRE) |
|
|
| |
|
National
Center for Research Resources (NCRR) of the National Institutes
of Health (NIH) invites applications for competing continuation
of Institutional Development Award (IDeA) Networks of Biomedical
Research Excellence (INBRE) grants to independent biomedical
research institutes and/or biomedical research institutions that
award doctoral degrees in the health sciences or sciences
related to health within IDeA-eligible states. INBRE
applications must represent a collaborative effort to sponsor
research with undergraduate institutions, community colleges and
tribal colleges and universities (TCUs).
The objectives of INBRE program are
to: 1) continue to build on the established multi-disciplinary
research network with a scientific focus to strengthen the lead
and partner institutions' biomedical research expertise and
infrastructure; 2) build and increase the research base and
capacity by providing support to faculty, postdoctoral fellows
and graduate students at the participating institutions; 3)
provide research opportunities for students from undergraduate
institutions, community colleges and TCUs and serve as a
"pipeline" for these students to continue in health research
careers within IDeA states; 4) enhance science and technology
knowledge of the state's workforce.
|
|
|
| |
|
|
|
|
| |
|
Letter of Intent
Receipt Date(s): June 22, 2009 and June 22, 2010; Application
Receipt Date(s): July 22, 2009, and July 22, 2010 |
|
|
| |
|
|
View |
Minority Access to Research Careers (MARC)
Ancillary Training Activities |
|
|
| |
|
Minority Access
to Research Careers (MARC) Branch of the Minority Opportunities in
Research (MORE) Division was established to significantly increase
the number and competitiveness of underrepresented minorities
engaged in biomedical research. To facilitate the training and
development of students, faculty, and/or researchers from groups
underrepresented in the biomedical research enterprise of this
nation, the MARC Branch will provide program-related support in
three key areas: a) scientific conferences, b) scientific short
courses, or c) other well-defined ancillary training activities that
further the MARC mission. |
|
|
| |
|
|
|
|
| |
|
Letters of Intent
Receipt Date(s): Not required;
Application Receipt or Submission
Date(s): September 11, 2008;
January 8, 2009; September 11, 2009; January 11, 2010; September 7,
2010; and January 11, 2011 |
|
|
| |
|
|
View |
PHS 2008-02 Omnibus Solicitation of the NIH,
CDC, and FDA for Small Business Innovation Research Grant
Applications (SBIR) |
|
|
| |
|
Funding Opportunity Announcement (FOA) issued by the National
Institutes of Health (NIH), the Centers for Disease Control and
Prevention (CDC), and the Food and Drug Administration (FDA) invites
eligible United States small business concerns (SBCs) to submit
Small Business Innovation Research (SBIR) grant applications. United
States SBCs that have the research capabilities and technological
expertise to contribute to the R&D mission(s) of the NIH, CDC and
FDA awarding components identified in this FOA are encouraged to
submit SBIR grant applications in response to identified topics (see
PHS 2008-2 SBIR/STTR Program
Descriptions and Research Topics for NIH, CDC, and FDA.)
|
|
|
| |
|
|
|
|
| |
|
Letters of Intent Receipt Date(s): Not
Applicable; Application Due Date(s): December 5, 2008 |
|
|
| |
|
|
View |
PHS 2008-02 Omnibus Solicitation of the NIH
for Small Business Technology Transfer Grant Applications (STTR) |
|
|
| |
|
Funding Opportunity Announcement (FOA)
issued by the National Institutes of Health (NIH) invites eligible
United States small business concerns (SBCs) to submit Small
Business Technology Transfer (STTR) grant applications. United
States SBCs that have the research capabilities and technological
expertise to contribute to the R&D mission(s) of the NIH awarding
components identified in this FOA are encouraged to submit STTR
grant applications in response to identified topics (see
PHS 2008-2 SBIR/STTR Program
Descriptions and Research Topics for NIH, CDC, and FDA.)
|
|
|
| |
|
|
|
|
| |
|
Letters of Intent Receipt Date(s): Not
Applicable; Application Due Date(s): December 5, 2008 |
|
|
| |
| |
View |
Department of Health and Human Services
National Institutes of Health Academic
Career Award |
|
|
| |
|
The purpose of the NIH Academic Career Award is to provide support
to increase the pool of individuals with academic and research
expertise to become academic researchers and to enhance the
educational or research capacity at the grantee sponsoring grantee
institution. The Academic Career Award supports Development awards
for more junior level candidates and Leadership awards for more
senior individuals with acknowledged scientific expertise and
leadership skills. |
|
|
| |
|
|
|
|
| |
|
Reoccurring: April 5, August 5 |
|
|
| |
| |
View |
Tools for Germplasm Cryopreservation (SBIR) |
|
|
| |
|
Tools for germplasm cryopreservation have become increasingly
important in enabling repositories to meet the needs for
establishing banks of animal germplasm for current and future
research needs. This funding opportunity announcement (FOA) solicits
applications from small business concerns (SBCs) for Small Business
Innovation Research (SBIR) projects that propose innovative research
in the areas of animal germplasm cryopreservation methods, reagents,
equipment, biosecurity, and the detection of disease, including the
vertical transmission of disease |
|
|
| |
|
|
|
|
| |
|
Reoccurring: April 5, August 5 |
|
|
| |
| |
View |
Centers of Excellence in Genomics Science (CEGS) |
|
|
| |
|
Centers of Excellence in Genomic Sciences (CEGS)
program establishes academic Centers for advanced genome research.
Each CEGS grant supports a multi-investigator, interdisciplinary
team to develop innovative genomic approaches to address a
particular biological problem. A CEGS project will address a
critical issue in genomic science, proposing a solution that would
be a very substantial advance. |
|
|
| |
|
|
|
|
| |
|
See Announcement |
|
|
| |
| |
View |
Omnibus Solicitation of the NIH, CDC, and
FDA for Small Business Innovation Research Grant Applications
|
|
|
| |
|
The SBIR program, as
established by law, is intended to meet the following goals:
- stimulate
technological innovation in the private sector;
- strengthen the role
of small business in meeting Federal research or research and
development (R/R&D) needs;
- increase the
commercial application of Federally-supported research results;
- foster and encourage
participation by socially and economically disadvantaged small
business concerns and women-owned business concerns in the SBIR
program; and
- improve the return on
investment from Federally-funded research for economic and
social benefits to the Nation.
The SBIR program is
structured in three phases, the first two of which are supported
using SBIR funds. The objective of Phase I is to establish the
technical/scientific merit and feasibility of the proposed R/R&D
efforts. The objective of Phase II is to continue the research or
R&D efforts initiated in Phase I. An objective of the SBIR program
is to increase private sector commercialization of innovations
derived from Federal R/R&D. The objective of Phase III, where
appropriate, is for the SBC to pursue with non-SBIR funds (either
Federal or non-Federal) the commercialization objectives resulting
from the results of the R/R&D funded in Phases I and II. In some
Federal agencies, Phase III may involve follow-on, non-SBIR funded
R&D, or production contracts for products or processes intended for
use by the U.S. Government. |
|
|
| |
|
|
|
|
| |
|
Due Date: December 5, 2008 |
|
|
| |
| |
View |
Omnibus Solicitation of the NIH for Small Business Technology
Transfer Grant Applications (Parent STTR |
|
|
| |
|
This Funding
Opportunity Announcement (FOA) issued by the National Institutes of
Health (NIH) invites eligible United States small business concerns
(SBCs) to submit Small Business Technology Transfer (STTR) grant
applications. United States SBCs
that have the research capabilities and technological expertise to
contribute to the R&D mission(s) of the NIH awarding components
identified in this FOA are encouraged to submit STTR grant
applications in response to identified topics (see
PHS 20SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA.)
|
|
|
| |
|
|
|
|
| |
|
Due Date: December 5, 2008 |
|
|
| |
| |
